Member Info for English_Parisien

In short, sit tight and hold (for gold, figuratively and literally speaking)!

- The company has REE’s, gold, copper and uranium; and seemingly lots of it!

- Quite how much and when can it be accessed, this remains to be seen.

- Boland MRE in 2025 (July, according to recent presentation and Edison report - although “step out drilling” is yet to come as per StockBox video from 10/04-25, so not sure if the July date is still achievable) followed by Scoping Study before year end, to begin commercialisation activities.

- In the financials, I infer that another raise will be required (“ The Group has £795,708 of cash and cash equivalents at 31 December 2024. The Group's and Company's ability to meet operational objectives and general overheads is reliant on raising further capital in the near future”). Whether this can be done at a higher price to minimise dilution remains to be seen.

- As far as I can see online, there is no publicised timeline of activities beyond 2025. I suppose this is deliberate whilst they cannot confirm exactly what they have

- I am unsure of what the plans are for 2026. Obviously things are advancing on multiple fronts and it may be that external parties come into the mix to help take things forward.

I would welcome other people’s thoughts.

But overall, very positive! Well done team COBRA.

Have a good day

- EP

Good morning and thank you!

Excellent. 2M of likely buys have since gone through this afternoon. Is that the magic of a good Twitter post or something more?

GLA - EP

Nice buy! You must be stacking up quite a position :)

Whilst we await sonic drilling results and progression towards the Maiden Resource Estimate, due in … November, from memory, if things haven’t slipped …

Has anyone any mid-to-long-term SP ambitions they wish to share? I know we’ve done some maths a while back, but not sure if anyone has any updates?

Whilst this is still relatively low key, I would like to try and acquire a high 6 figure or low 7 figure share stake. But the concept of a 10p or 25p share price makes me a little giddy at the idea of a holding worth up to £250k. But I am not sure whether this is wholly achievable …

Anyway, lunchtime musings before back to work!

GLA and enjoy the sun if you can

- EP

Https://www.tipranks.com/news/company-announcements/regent-pacific-announces-2025-agm-and-key-resolutions

Whether it’s a positive reaction to the AGM news?

I long left this as it appeared to have died a death.

Good luck

Summit therapeutics, in collaboration with Akeso, is also hot on the tail on Merck and Keytruda.

Would be great to see Sareum proudly showcasing at European Lung Cancer Congress (ELCC 2026) or the World Conference on Lung Cancer (WCLC 2025), if applicable.

Think the only advertised event currently on the website is the BIO International Convention 2025.

Really good to see the company showcasing its efforts in yesterday’s RNS. Hopefully it will attract attention from big pharma. I am just frustrated I took my eye off the ball with the 11p SP last month! But nevermind :)

GLA

- EP

Https://seekingalpha.com/article/4778489-summit-therapeutics-new-ivonescimab-data-raise-concerns

Yep … the recent 50% rise was not underpinned by anything other than sentiment. some confusion over the news from yesterday combined with profit taking and no doubt some algorithms at play seemingly caused the 35% plunge.

The long-term view still remains positive. The paper loss from yesterday was painful though. I’ve not yet the confidence to practice trimming of stock to maximise peaks like we saw here, with a view to buying back on the dip.

Live and learn I suppose.

Have a good weekend

EP

Released 40 mins ago ?

https://www.marketwatch.com/press-release/ivonescimab-receives-nmpa-approval-for-first-line-treatment-of-pd-l1-positive-nsclc-based-on-breakthrough-head-to-head-phase-iii-trial-demonstrating-superior-efficacy-over-pembrolizumab-2418337f

Don’t think a raise is considered T1.

In my opinion, either positive: a form of partnership or takeover (Summit being taken over, summit taking over Akeso, some sort of major licensing) … or very very bad … data problem of one form or another

But given that the directors just bought 6M$ of shares recently … I cannot see this being negative, even if I am biased.

I am guessing this will now be halted until close of market and then news released for the weekend.

But what do I know … my message this morning appears currently to have aged badly !

GLA

- EP

Trading halted. Code T1.

The NASDAQ and Stock Halts

T1: Halt – News Pending: Trading is halted pending the release of significant (or material) news.

And just seen this:

https://uk.investing.com/news/company-news/summit-therapeutics-stock-soars-to-alltime-high-of-3405-93CH-4046297

It’s hard not to start getting a little excited and less-cautiously optimistic.

Obviously, until such a time that we get confirmed P3 readouts and FDA approval, this is all pure and positive speculation … but should they indeed pull it off, then we are in for a ride!

I was musing this week over “ had I loaded up an ISA when the share price was 1$, I would currently be sitting on 1 million dollars just now”. Mind boggling.

Back to the grindstone. And let’s see what this afternoon holds.

GLA - EP

Https://www.businesswire.com/news/home/20250424810995/en/Summit-Therapeutics-to-Host-First-Quarter-2025-Financial-Results-Operational-Progress-Call-on-May-1-2025

Not sure if this has triggered anything …

The SP just took off at the end.

GLA - EP

It will certainly be interesting.

It’s unclear how much has already been baked in as anticipation of good news and therefore how much more upward room there is yet to come.

I think the highest of the recent target prices was circa $45, which is “only” a further 50% uptick from where we currently are.

As for strategies, each to their own. Still lots of upward potential. But where the current ceiling is … who knows?!

Looks like some have known since Monday, judging by the SMMT upward trajectory of the SP. Or equally since the 16th.

In any case, all positive. Looks like SMMT might soon be retesting the highs of last year.

I will be intrigued to see quite how high this goes and what the Board actually decide to do in terms of the longer term: license, T/O, run in collaboration with a pharma (Pfizer for example), ...

GLA - EP

Akeso all time high, breaking the $90 HKD mark!

Https://www.proactiveinvestors.co.uk/companies/news/1069514/greatland-gold-to-become-greatland-resources-as-it-restructures-for-asx-listing-1069514.html

I know it's been talked about in the past; here is another Goldie on AIM doing just that.

I've no opinion either way on the matter, just for information.

Have a good weekend

- EP

And the USD is down, meaning we get money GBP for our buck!

I am excited to see where this might go. Seeing numbers from $30-100 a share being bandied around of late has both made me chuckle and have my jaw hit the floor at the same time.

If I could Time Machine, I would go back to $1 a share and load up. But alas … I am however grateful to have a free position just now and eager to see where this goes next!